Picture of Alembic Pharmaceuticals logo

APLLTD — Alembic Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Alembic Pharmaceuticals Says USFDA Issues Form 483 With 4 Observations After Inspection

March 8 (Reuters) - Alembic Pharmaceuticals Ltd
 ALEM.NS :
    * USFDA HAS CONDUCTED AN INSPECTION AT OUR ONCOLOGY
FORMULATION
FACILITY AT PANELAV
    * USFDA ISSUED A FORM 483 WITH FOUR PROCEDURAL OBSERVATION

Source text for Eikon:  ID:nBSE96jTwf 
Further company coverage:  ALEM.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alembic Pharmaceuticals

See all news